Targeting MicroRNAs in Cancer Gene Therapy

Por Ji, Weidan, Sun, Bin, Su, Changqing
Publicado no Genes (Basel) (2017)

Clinicopathological and Prognostic Significance of Survivin Over-Expression in Patients with Esophageal Squamous Cell Carcinoma: A Meta-Analysis

Por Li, Chunguang, Li, Zhigang, Zhu, Maoling, Zhao, Tiejun, Chen, Ling, Ji, Weidan, Chen, Hezhong, Su, Changqing
Publicado em 2012

Costunolide and dehydrocostuslactone combination treatment inhibit breast cancer by inducing cell cycle arrest and apoptosis through c-Myc/p53 and AKT/14-3-3 pathway

Por Peng, Zhangxiao, Wang, Yan, Fan, Jianhui, Lin, Xuejing, Liu, Chunying, Xu, Yang, Ji, Weidan, Yan, Chao, Su, Changqing
Publicado no Sci Rep (2017)

Transcriptional factor OCT4 promotes esophageal cancer metastasis by inducing epithelial-mesenchymal transition through VEGF-C/VEGFR-3 signaling pathway

Por Li, Chunguang, Zhu, Maoling, Lou, Xiaoli, Liu, Chunying, Chen, Hezhong, Lin, Xuejing, Ji, Weidan, Li, Zhigang, Su, Changqing
Publicado no Oncotarget (2017)

OCT4 Positively Regulates Survivin Expression to Promote Cancer Cell Proliferation and Leads to Poor Prognosis in Esophageal Squamous Cell Carcinoma

Por Li, Chunguang, Yan, Yan, Ji, Weidan, Bao, Longlong, Qian, Haihua, Chen, Lei, Wu, Mengchao, Chen, Hezhong, Li, Zhigang, Su, Changqing
Publicado em 2012

hSulf-1 Gene Exhibits Anticancer Efficacy through Negatively Regulating VEGFR-2 Signaling in Human Cancers

Por Ji, Weidan, Yang, Jiahe, Wang, Duanming, Cao, Lu, Tan, Weifeng, Qian, Haihua, Sun, Bin, Qian, Qijun, Yin, Zhengfeng, Wu, Mengchao, Su, Changqing
Publicado em 2011

A Novel Matrine Derivative WM130 Inhibits Activation of Hepatic Stellate Cells and Attenuates Dimethylnitrosamine-Induced Liver Fibrosis in Rats

Por Xu, Yang, Peng, Zhangxiao, Ji, Weidan, Li, Xiang, Lin, Xuejing, Qian, Liqiang, Li, Xiaoya, Chai, Xiaoyun, Wu, Qiuye, Gao, Quangen, Su, Changqing
Publicado no Biomed Res Int (2015)

Therapeutic strategy with artificially-designed i-lncRNA targeting multiple oncogenic microRNAs exhibits effective antitumor activity in diffuse large B-cell lymphoma

Por Su, Yinghan, Sun, Bin, Lin, Xuejing, Zhao, Xinying, Ji, Weidan, He, Miaoxia, Qian, Haihua, Song, Xianmin, Yang, Jianmin, Wang, Jianmin, Chen, Jie
Publicado no Oncotarget (2016)

Volatile oil from Saussurea lappa exerts antitumor efficacy by inhibiting epithelial growth factor receptor tyrosine kinase-mediated signaling pathway in hepatocellular carcinoma

Por Lin, Xuejing, Peng, Zhangxiao, Fu, Xiaohui, Liu, Chunying, Xu, Yang, Ji, Weidan, Fan, Jianhui, Chen, Lei, Fang, Lin, Huang, Yao, Su, Changqing
Publicado no Oncotarget (2016)

OCT4 increases BIRC5 and CCND1 expression and promotes cancer progression in hepatocellular carcinoma

Por Cao Lu, Li Chunguang, Shen Shuwen, Yan Yan, Ji Weidan, Wang Jinghan, Qian Haihua, Jiang Xiaoqing, Li Zhigang, Wu Mengchao, Zhang Ying, Su Changqing
Publicado em 2013-02-01

OCT4 increases BIRC5 and CCND1 expression and promotes cancer progression in hepatocellular carcinoma

Por Cao, Lu, Li, Chunguang, Shen, Shuwen, Yan, Yan, Ji, Weidan, Wang, Jinghan, Qian, Haihua, Jiang, Xiaoqing, Li, Zhigang, Wu, Mengchao, Zhang, Ying, Su, Changqing
Publicado em 2013

Survivin promoter-regulated oncolytic adenovirus with Hsp70 gene exerts effective antitumor efficacy in gastric cancer immunotherapy

Por Wang, Weiguo, Ji, Weidan, Hu, Huanzhang, Ma, Juming, Li, Xiaoya, Mei, Weiqun, Xu, Yang, Hu, Huizhen, Yan, Yan, Song, Qizhe, Li, Zhigang, Su, Changqing
Publicado em 2013

Sulfatase 1 (hSulf-1) reverses basic fibroblast growth factor-stimulated signaling and inhibits growth of hepatocellular carcinoma in animal model

Por Xu, Gaoya, Ji, Weidan, Su, Yinghan, Xu, Yang, Yan, Yan, Shen, Shuwen, Li, Xiaoya, Sun, Bin, Qian, Haihua, Chen, Lei, Fu, Xiaohui, Wu, Mengchao, Su, Changqing
Publicado em 2014

Targeted Hsp70 expression combined with CIK-activated immune reconstruction synergistically exerts antitumor efficacy in patient-derived hepatocellular carcinoma xenograft mouse mo...

Por Hu, Huanzhang, Qiu, Yinghe, Guo, Minggao, Huang, Yao, Fang, Lin, Peng, Zhangxiao, Ji, Weidan, Xu, Yang, Shen, Shuwen, Yan, Yan, Huang, Xuandong, Zheng, Junnian, Su, Changqing
Publicado no Oncotarget (2014)